Tasquinimod

Tasquinimod for the Treatment of Relapsed or Refractory Myeloma

Arms / Cohorts

Experimental Arm A2:Arm A2: Tasquinimod (Dose Expansion)

Accepting patients

Experimental Arm B2:Arm B2: Tasquinimod + Ixazomib + Lenalidomide + Dexamethasone (Dose Expansion)

Accepting patients

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print Report

Print this trial to share with your doctor.

(888) 828-2206

We can help answer any questions and connect you (or your patient) with the study team.

Schedule Call

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.